Frailty consensus: A call to action

Journal of the American Medical Directors Association

Volumn 14, Issue 6, 2013, Pages 392-397

  Morley, John E ^a   Vellas, Bruno ^b,c   Abellan van Kan, G ^b,c   Anker, Stefan D ^d,e   Bauer, Juergen M ^f,g   Bernabei, Roberto ^h   Cesari, Matteo ^b,c   Chumlea, W C ⁱ   Doehner, Wolfram ^d   Evans, Jonathan ^j   Fried, Linda P ^k   Guralnik, Jack M ^l   Katz, Paul R ^m   Malmstrom, Theodore K ^a   McCarter, Roger J ⁿ   Gutierrez Robledo, Luis M ^o   Rockwood, Ken ^p   von Haehling, Stephan ^d   Vandewoude, Maurits F ^q   Walston, Jeremy ^r  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Faculté de Médecine Centre Hospitalo universitaire   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e IRCCS san Rafaette   (Italy)

^f UNIVERSITY OF OLDENBURG   (Germany)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h CATHOLIC UNIVERSITY   (Italy)

ⁱ WRIGHT STATE UNIVERSITY   (United States)

^j American Medical Directors Association (AMDA)   (United States)

^k Department of Medicine   (United States)

^l UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ PENNSYLVANIA STATE UNIVERSITY   (United States)

^o INSTITUTO NACIONAL DE GERIATRÍA   (Mexico)

^p DALHOUSIE UNIVERSITY   (Canada)

^q UNIVERSITY OF ANTWERP   (Belgium)

^r JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Comorbidities; Frailty; Physical frailty; Rapid screening tests; Weight loss

Indexed keywords

VITAMIN D;

ARTICLE; CALORIC INTAKE; CONSENSUS; CONSENSUS DEVELOPMENT; EXERCISE; FRAILTY; HEALTH STATUS; HUMAN; MEDICAL SOCIETY; PHYSICIAN; POLYPHARMACY; PRACTICE GUIDELINE; PROTEIN DIET; RATING SCALE; RISK ASSESSMENT; SCREENING TEST; SUPPLEMENTATION; SYNDROME; TREATMENT PLANNING; WEIGHT REDUCTION;

EID: 84878860296     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.03.022     Document Type: Article

References (98)

1. Walston J., Hadley E.C., Ferrucci L., et al. Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006, 54:991-1001.
2. Cerreta F., Eichler H.G., Rasi G. Drug policy for an aging population-the European Medicines Agency's geriatric medicines strategy. N Engl J Med 2012, 367:1972-1974.
3. Available at: Accessed April 22, 2013. http://ec.europa.eu/economy_finance/publications/european_economy/2012/pdf/ee-2012-2_en.pdf.
4. Rockwood K., Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med 2011, 27:17-26.
5. Fried L.P., Ferrucci L., Darer J., et al. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004, 59:255-263.
6. Sourial N., Bergman H., Karunananthan S., et al. Contribution of frailty markers in explaining differences among individuals in five samples of older persons. J Gerontol A Biol Sci Med Sci 2012, 67:1197-1204.
7. Collard R.M., Boter H., Schoevers R.A., Oude Voshaar R.C. Prevalence of frailty in community-dwelling older persons: A systematic review. J Am Geriatr Soc 2012, 60:1487-1492.
8. Rodríguez-Mañas L., Féart C., Mann G., et al. Searching for an operational definition of frailty: A Delphi method based consensus statement. The Frailty Operative Definition-Consensus Conference Project. J Gerontol A Biol Sci Med Sci 2013, 68:62-67. on behalf of the FOD-CC group.
9. Rockwood K. What would make a definition of frailty successful?. Age Ageing 2005, 34:432-434.
10. Fried L.P., Tangen C.M., Walston J., et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-M156.
11. Bandeen-Roche K., Xue Q.L., Ferrucci L., et al. Phenotype of frailty: Characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci 2006, 61:262-266.
12. Ensrud K.E., Ewing S.K., Taylor B.C., et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 2008, 168:382-389.
13. Kiely D.K., Cupples L.A., Lipsitz L.A. Validation and comparison of two frailty indexes: The MOBILIZE Boston Study. J Am Geriatr Soc 2009, 57:1532-1539.
14. Rockwood K., Abeysundera M.J., Mitnitski A. How should we grade frailty in nursing home patients?. J Am Med Dir Assoc 2007, 8:595-603.
15. Rockwood K., Mitnitski A., Song X., et al. Long-term risks of death and institutionalization of elderly people in relation to deficit accumulation at age 70. J Am Geriatr Soc 2006, 54:975-979.
16. Abellan van Kan G., Rolland Y.M., Morley J.E., Vellas B. Frailty: Toward a clinical definition. J Am Med Dir Assoc 2008, 9:71-72.
17. Abellan van Kan G., Rolland Y., Bergman H., et al. The I.A.N.A. Task Force on Frailty assessment of older people in clinical practice. J Nutr Health Aging 2008, 12:29-37.
18. Romero-Ortuno R. The Frailty Instrument of the Survey of Health, Ageing and Retirement in Europe (SHARE-FI) predicts mortality beyond age, comorbidities, disability, self-rated health, education and depression. Eur Geriatr Med 2011, 2:323-326.
19. Romero-Ortuno R., Walsh C.D., Lawlor B.A., Kenny R.A. A frailty instrument for primary care: Findings from the Survey of Health, Ageing and Retirement in Europe (SHARE). BMC Geriatr 2010, 10:57.
20. Min L.C., Elliott M.N., Wenger N.S., Saliba D. Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people. J Am Geriatr Soc 2006, 54:507-511.
21. Min L., Yoon W., Mariano J., et al. The vulnerable elders-13 survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients. J Am Geriatr Soc 2009, 57:2070-2076.
22. Biganzoli L., Boni L., Becheri D., et al. Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?. Ann Oncol 2013, 24:494-500.
23. Gobbens R.J., van Assen M.A., Luijkx K.G., et al. The Tilberg Frailty Indicator: Psychometric properties. J Am Med Dir Assoc 2010, 11:344-355.
24. Gobbens R.J., van Assen M.A., Luijkx K.G., et al. Determinants of frailty. J Am Med Dir Assoc 2010, 11:356-364.
25. Peters L.L., Boter H., Buskens E., Slaets J.P. Measurement properties of the Groningen Frailty Indicator in home-dwelling and institutionalized elderly people. J Am Med Dir Assoc 2012, 13:546-551.
26. Hoogendijk E.O., van Hout H.P. Investigating measurement properties of the Groningen Frailty Indicator: A more systematic approach is needed. J Am Med Dir Assoc 2012, 13:757.
27. Morley J.E., Abbatecola A.M., Argiles J.M., et al. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 2011, 12:403-409.
28. Fielding R.A., Vellas B., Evans W.J., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011, 12:249-256.
29. Muscaritoli M., Anker S.D., Argiles J., et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting disease" and "nutrition in Geriatrics." Clin Nutr 2010, 29:154-159.
30. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39:412-423.
31. Von Haehling S., Morley J.E., Anker S.D. From muscle wasting to sarcopenia and myopenia: Update 2012. J Cachexia Sarcopenia Muscle 2012, 3:213-217.
32. Morley J.E. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009, 15:3384-3395.
33. Lacas A., Rockwood K. Frailty in primary care: A review of its conceptualization and implications for practice. BMC Med 2012, 10:4.
34. Pialoux T., Goyard J., Lesourd B. Screening tools for frailty in primary health care: A systematic review. Geriatr Gerontol Int 2012, 12:189-197.
35. Sternberg S.A., Wershof Schwartz A., Karunananthan S., et al. The identification of frailty: A systematic literature review. J Am Geriatr Soc 2011, 59:2129-2138.
36. Hubbard R.E., Rockwood K. Frailty in older women. Maturitas 2011, 69:203-207.
37. Pijpers E., Ferreira I., Stehouwer C.D., et al. The frailty dilemma. Review of the predictive accuracy of major frailty scores. Eur J Intern Med 2012, 23:118-123.
38. Morley J.E. Frailty: Diagnosis and management. J Nutr Health Aging 2011, 15:667-670.
39. Shamliyan T., Talley K.M., Ramakrishnan R., Kane R.L. Association of frailty with survival: A systematic literature review. Ageing Res Rev 2012, Mar 12 [Epub ahead of print].
40. Tinetti M.E., Fried T.R., Boyd C.M. Designing health care for the most common chronic condition-multimorbidity. JAMA 2012, 307:2493-2494.
41. Rockwood K., Song X., MacKnight C., et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005, 173:489-495.
42. Royal College of Physicians. Acute Care Toolkit 3: Acute Medical Care for Frail Older people. March 2012. Available at: Accessed December 20, 2012. http://www.rcplondon.ac.uk/sites/default/files/acute-care-toolkit-3.pdf.
43. Rolland Y., Benetos A., Gentric A., et al. Frailty in older population: A brief position paper from the French society of geriatrics and gerontology. Geriatr Psychol Neuropsychiatr Vieil 2011, 9:387-390.
44. Hyde Z., Flicker L., Almeida O.P., et al. Low free testosterone predicts frailty in older men: The Health in Men study. J Clin Endocrinol Metab 2010, 95:3165-3172.
45. Lopez D., Flicker L., Dobson A. Validation of the frail scale in a cohort of older Australian women. J Am Geriatr Soc 2012, 60:171-173.
46. Morley J.E., Malmstrom T.K., Miller D.K. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 2012, 16:601-608.
47. Woo J., Leung J., Morley J.E. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 2012, 60:1478-1486.
48. Subra J., Gillette-Guyonnet S., Cesari M., et al. The integration of frailty into clinical practice: Preliminary results from the Gérontopôle. J Nutr Health Aging 2012, 16:714-720.
49. Singh N.A., Quine S., Clemson L.M., et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. J Am Med Dir Assoc 2012, 13:24-30.
50. Yamada M., Arai H., Sonoda T., Aoyama T. Community-based exercise program is cost-effective by preventing care and disability in Japanese frail older adults. J Am Med Dir Assoc 2012, 13:507-511.
51. Theou O., Stathokostas L., Roland K.P., et al. The effectiveness of exercise interventions for the management of frailty: A systematic review. J Aging Res 2011, 2011:569194.
52. Gillespie L.D., Robertson M.C., Gillespie W.J., et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2012, (9):CD007146.
53. Landi F., Laviano A., Cruz-Jentoft A.J. The anorexia of aging: Is it a geriatric syndrome?. J Am Med Dir Assoc 2010, 11:153-156.
54. Morley J.E. Undernutrition: A major problem in nursing homes. J Am Med Dir Assoc 2011, 12:243-246.
55. Morley J.E. Weight loss in older persons: New therapeutic approaches. Curr Pharm Des 2007, 13:3637-3647.
56. Milne A.C., Potter J., Vivanti A., Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2009, (2):CD003288.
57. van Wetering C.R., Hoogendoorn M., Broekhuizen R., et al. Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: A prespecified subgroup analysis of the INTERCOM trial. J Am Med Dir Assoc 2010, 11:179-187.
58. Neelemat F., Bosmans J.E., Thijs A., et al. Post-discharge nutritional support in malnourished elderly individuals improves functional limitations. J Am Med Dir Assoc 2011, 12:295-301.
59. Morley M.E., Argiles J.M., Evans W.J., et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010, 11:391-396.
60. Tieland M., van de Rest O., Dirks M.L., et al. Protein supplementation improves physical performance in frail elderly people: A randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012, 13:720-726.
61. Volpi E., Campbell W.W., Dwyer J.T., et al. Is the optimal level of protein intake for older adults greater than the recommended dietary allowance?. J Gerontol A Biol Sci Med Sci 2012, Nov 26 [Epub ahead of print].
62. Paddon-Jones D. Perspective: Exercise and protein supplementation in frail elders. J Am Med Dir Assoc 2013, 14:73-74.
63. Malafarina V., Uriz-Otano F., Iniesta R., Gil-Guerrero L. Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: A systematic review. J Am Med Dir Assoc 2013, 14:10-17.
64. Tieland M., Dirks M.L., van der Zwaluw N., et al. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: A randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012, 13:713-719.
65. Morley J.E. Do frail older persons need more protein?. J Am Med Dir Assoc 2012, 13:667-668.
66. Cawood A.L., Elia M., Stratton R.J. Systematic review and meta-analysis of the effects of high protein oral nutritional supplements. Ageing Res Rev 2012, 11:278-296.
67. Waters D.L., Vawter R., Qualls C., et al. Long-term maintenance of weight loss after lifestyle intervention in frail, obese older adults. J Nutr Health Aging 2013, 17:3-7.
68. Murad M.H., Elamin K.B., Abu Elnour N.O., et al. Clinical review: The effect of vitamin D on falls: A systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96:2997-3006.
69. Bischoff-Ferrari H.A., Willett W.C., Orav E.J., et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012, 567:40-49.
70. Rejnmark L., Avenell A., Masud T., et al. Vitamin D with calcium reduces mortality: Patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab 2012, 97:2670-2681.
71. Muir S.W., Montero-Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: A systematic review and meta-analysis. J Am Geriatr Soc 2011, 59:2291-2300.
72. Rolland Y., Onder G., Morley J.E., et al. Current and future pharmacologic treatment of sarcopenia. Clin Geriatr Med 2011, 27:423-447.
73. Sukuma K., Yamaguchi A. Molecular mechanisms in aging and current strategies to counteract sarcopenia. Curr Aging Sci 2010, 3:90-101.
74. Gnjidic D., Hilmer S.N., Blyth F.M., et al. Polypharmacy cutoff and outcomes: Five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 2012, 65:989-995.
75. Flaherty J.H., Perry H.M., Lynchard G.S., Morley J.E. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci 2000, 55:M554-M559.
76. Rockwood K. Medical management of frailty: Confessions of a gnostic. CMAJ 1997, 157:1081-1084.
77. Bronskill S.E., Gill S.S., Paterson J.M., et al. Exploring variation in rates of polypharmacy across long term care homes. J Am Med Dir Assoc 2012, 13:309.e15-309.e21.
78. Gokce Kutsal Y., Barak A., Atalay A., et al. Polypharmacy in the elderly: A multicenter study. J Am Med Dir Assoc 2009, 10:486-490.
79. Kojima G., Bell C., Tamura B., et al. Reducing cost by reducing polypharmacy: The polypharmacy outcomes project. J Am Med Dir Assoc 2012, 13:818.e11-818.e15.
80. Fitzgerald S.P., Bean N.G. An analysis of the interactions between individual comorbidities and their treatments-implications for guidelines and polypharmacy. J Am Med Dir Assoc 2010, 11:475-484.
81. Tamura B.K., Bell C.L., Lubimir K., et al. Physician intervention for medication reduction in a nursing home: The polypharmacy outcomes project. J Am Med Dir Assoc 2011, 12:326-330.
82. Morley J.E. Polypharmacy in the nursing home. J Am Med Dir Assoc 2009, 10:289-291.
83. Merle L., Laroche M.L., Dantoine T., Charmes J.P. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 2006, 22:375-392.
84. Resnick B., Pacala J.T. 2012 Beers Criteria. J Am Geriatr Soc 2012, 60:612-613.
85. Gallagher P., Ryan C., Byrne S., et al. STOPP (Screening Tool of Older Person's Prescription) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008, 46:72-83.
86. Pyszka L.L., Seys Ranola T.M., Milhans S.M. Identification of inappropriate prescribing in geriatrics at a Veterans Affairs hospital using STOPP/START screening tools. Consult Pharm 2010, 25:365-373.
87. Theou O., Rockwood K. Should frailty status always be considered when treating the elderly patient?. Aging Health 2012, 8:261-271.
88. Espinoza S., Walston J.D. Frailty in older adults: Insights and interventions. Cleve Clin J Med 2005, 72:1105-1112.
89. Vellas B., Cestac P., Morley J.E. Implementing frailty into clinical practice: We cannot wait. J Nutr Health Aging 2012, 16:599-600.
90. Ogawa K., Fujiwara Y., Yoshida H., et al. [The validity of the "Kihon Checklist" as an index of frailty and its biomarkers and inflammatory markers in elderly people.]. Nihon Ronen Igakkai Zasshi 2011, 48:545-552. Japanese.
91. Tomata Y., Hozawa A., Ohmori-Matsuda K., et al. [Validation of the Kihon Checklist for predicting the risk of 1-year incident long term care insurance certification: The Ohsaki Cohort 2006 Study.]. Nihon Koshu Eisei Zasshi 2011, 58:3-13. Japanese.
92. Fukutomi E., Okumiya K., Wada T., et al. Importance of cognitive assessment as part of the "Kihon Checklist" developed by the Japanese Ministry of Health, Labor and Welfare for prediction of frailty at a 2-year follow up. Geriatr Gerontol Int 2012, Nov 22, [Epub ahead of print].
93. Afilalo J. Frailty in patients with cardiovascular disease: Why, when and how to measure. Curr Cardiovasc Risk Rep 2011, 5:467-472.
94. Ruiz M., Reske T., Cefalu C., Estrada J. Management of elderly and frail elderly patients: The importance of comprehensive geriatrics assessment and the need for guidelines. Am J Med Sci 2012, Nov 17 [Epub ahead of print].
95. Shilpak M.G., Stehman-Breen C., Fried L.F., et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis 2004, 43:861-867.
96. Desquilbet L., Jacobson L.P., Fried L.P., et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007, 62:1279-1286.
97. Sinclair A., Morley J.E., Rodriguez-Mañas L., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 2012, 13:497-502.
98. Partridge J.S., Harari D., Dhesi J.K. Frailty in the older surgical patient: A review. Age Ageing 2012, 41:142-147.